
DNA Star Inc (AKA: DNAstar Inc) Profile last edited on: 2/20/2019
CAGE: 0KRF2
UEI: MM8CFNUNTBL7
Business Identifier: Software products for DNA and protein analysis Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 02
County: Dane
Congr. District: 02
County: Dane
Public Profile
Spun out of the University of Wisconsin, DNASTAR, Inc. develops software solutions for molecular biology, genomics, and structural biology, focusing on DNA and protein analysis products. The company offers GenVision, a data visualization software application; ArrayStar, a microarray gene expression visualization and analysis tool; and SeqMan NGen, a software solution for sequence assembly of illumina, life sciences, and sanger data. The company also provides Lasergene, a sequence analysis software suite, which includes SeqBuilder, which is used for visualization and sequence editing applications; SeqMan Pro, which is used for sequence assembly, SNP discovery, and reporting applications; MegAlign, which is used for sequence alignment applications; PrimerSelect, which is used for oligo primer design applications; Protean, which is used for protein structure analysis and prediction applications; GeneQuest, which is used for gene finding applications; and EditSeq, which is used to import various file types. In addition, it sponsors for scientific seminars and conferences. The companys products are used by pharmaceutical, biotechnology, and academic researchers in the United States and internationally. The company's technology has a variety of applications in cloning and gene discovery. The firm is positioned as a leader in the global Next Generation Sequencing (NGS) informatics market forecast to grow significantly (22%) by the early 2020s to a total of $1.3 Billion.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
25-49Revenue Range
2.5M-5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2024 | 2 | NIH | $1,330,705 | |
Project Title: Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets | ||||
2023 | 2 | NIH | $5,017,302 | |
Project Title: Rapid Structure-Based Software to Enhance Antibody Affinity and Developability for High-Throughput Screening | ||||
2021 | 2 | NIH | $1,500,000 | |
Project Title: Long Read Based Sequencing Software for the Comprehensive Analysis of Clinical Samples | ||||
2019 | 2 | NIH | $1,649,983 | |
Project Title: Scalable Post-Assembly Editing Software for Finishing and Annotating Personal Genomes | ||||
2018 | 2 | NIH | $1,566,575 | |
Project Title: Complete Genome De Novo Assembly Software for the Emerging Long Read Sequencing ERA |
Key People / Management
Frederick R Blattner -- President
Carolyn F Allex
Schuyler Baldwin
Carolyn F Cassel
Steven Joseph Darnell
Philip Doggett
Timothy J Durfee
Ann Johnson
Gerald Miller
John Schroeder
Tom Shwei
Carolyn F Allex
Schuyler Baldwin
Carolyn F Cassel
Steven Joseph Darnell
Philip Doggett
Timothy J Durfee
Ann Johnson
Gerald Miller
John Schroeder
Tom Shwei